Design and development of a peptide-based adiponectin receptor agonist for cancer treatment

<p>Abstract</p> <p>Background</p> <p>Adiponectin, a fat tissue-derived adipokine, exhibits beneficial effects against insulin resistance, cardiovascular disease, inflammatory conditions, and cancer. Circulating adiponectin levels are decreased in obese individuals, and this feature correlates with increased risk of developing several metabolic, immunological and neoplastic diseases. Thus, pharmacological replacement of adiponectin might prove clinically beneficial, especially for the obese patient population. At present, adiponectin-based therapeutics are not available, partly due to yet unclear structure/function relationships of the cytokine and difficulties in converting the full size adiponectin protein into a viable drug.</p> <p>Results</p> <p>We aimed to generate adiponectin-based short peptide that can mimic adiponectin action and be suitable for preclinical and clinical development as a cancer therapeutic. Using a panel of 66 overlapping 10 amino acid-long peptides covering the entire adiponectin globular domain (residues 105-254), we identified the 149-166 region as the adiponectin active site. Three-dimensional modeling of the active site and functional screening of additional 330 peptide analogs covering this region resulted in the development of a lead peptidomimetic, ADP 355 (H-DAsn-Ile-Pro-Nva-Leu-Tyr-DSer-Phe-Ala-DSer-NH₂). In several adiponectin receptor-positive cancer cell lines, ADP 355 restricted proliferation in a dose-dependent manner at 100 nM-10 μM concentrations (exceeding the effects of 50 ng/mL globular adiponectin). Furthermore, ADP 355 modulated several key signaling pathways (AMPK, Akt, STAT3, ERK1/2) in an adiponectin-like manner. siRNA knockdown experiments suggested that ADP 355 effects can be transmitted through both adiponectin receptors, with a greater contribution of AdipoR1. <it>In vivo</it>, intraperitoneal administration of 1 mg/kg/day ADP 355 for 28 days suppressed the growth of orthotopic human breast cancer xenografts by ~31%. The peptide displayed excellent stability (at least 30 min) in mouse blood or serum and did not induce gross toxic effects at 5-50 mg/kg bolus doses in normal CBA/J mice.</p> <p>Conclusions</p> <p>ADP 355 is a first-in-class adiponectin receptor agonist. Its biological activity, superior stability in biological fluids as well as acceptable toxicity profile indicate that the peptidomimetic represents a true lead compound for pharmaceutical development to replace low adiponectin levels in cancer and other malignancies.</p

Environmental influences on the photooxidation of manganese by a zinc porphyrin sensitizer

The photosensitized oxidation of a membrane-bound Mn(III) tetrapyridylporphyrin derivative by a Zn tetrapyridylporphyrin derivative, which is confined to the membrane, has been achieved in negatively charged membranes consisting of phosphatidylglycerol or phosphatidic acid. At the same time, the zwitterionic electron acceptor, propylviologen sulfonate (PVS(0)), is reduced in the aqueous phase. The same reaction cannot be obtained with zwitterionic or cationic membranes, nor does this photosensitized reaction take place in a homogeneous solution with Mn(III) tetrapyridylporphyrin and Zn tetrapyridylporphyrin. These results show that the organization of donor, sensitizer, and acceptor at an appropriately selected interface allows reactions that would not occur in homogeneous solutions

Photosensitized electron transport across lipid vesicle walls: Enhancement of quantum yield by ionophores and transmembrane potentials

The photosensitized reduction of heptylviologen in the bulk aqueous phase of phosphatidylcholine vesicles containing EDTA inside and a membrane-bound tris(2,2′-bipyridine)ruthenium(2+) derivative is enhanced by a factor of 6.5 by the addition of valinomycin in the presence of K(+). A 3-fold stimulation by gramicidin and carbonyl cyanide m-chlorophenylhydrazone is observed. The results suggest that, under these conditions, the rate of photoinduced electron transfer across vesicle walls in the absence of ion carriers is limited by cotransport of cations. The rate of electron transfer across vesicle walls could be influenced further by generating transmembrane potentials with K(+) gradients in the presence of valinomycin. When vesicles are made with transmembrane potentials, interior more negative, the quantum yield of heptylviologen reduction is doubled, and, conversely, when vesicles are made with transmembrane potentials, interior more positive, the quantum yield is decreased and approaches the value found in the absence of valinomycin

PHOTOINDUCED TRANSFER OF OXYGEN FROM WATER: AN ARTIFICAL PHOTOSYNTHETIC SYSTEM

The photoinduced splitting of water into hydrogen and oxygen has evoked great interest in recent years as a means for energy storag eand fuel production. Photoinduced reduction of water to hydrogen, using visible light, has been described using heterogeneous or homogeneous catalysts. However, the complementary part involving the oxidation of water to oxygen is required in order to create a cyclic artificial 'photosynthetic' fuel system. The major difficulty assocaited with the photooxidation of water involves the requirement for a four electron transfer to produce oxygen. A stepwise one-electron oxidation of water is unfavorable due to the implied formation of active hydroxyl radicals. Very recently, it has been reported that RuO{sub 2} can serve as a heterogeneous charge storage catalyst for oxygen production. On the basis of the limited knowledge about natural photosynthesis, in which manganese ions play an important role in oxygen evolution, synthetic manganese complexes, and in particular dimeric complexes, have been proposed as potential catalysts for oxygen production. So far, efforts directed toward this goal have been unsuccessful. Consequently, using a manganese complex, they attempted to perform a photoinduced oxidation of water whereby the active oxygen is transferred to a trapping substrate. In such a way, the requirement for a dimerization process to evolve molecular oxygen is avoided. They wish to report a photoinduced redox cycle sensitized by a manganese porphyrin, 5-(4{prime}-hexadecylpyridium)-10, 15, 20-tri (4{prime}-pyridyl)-porphinatomanganese(III) (abbreciated to Pn-Mn{sup III}) in which the resultant reaction is the oxidation of water and trapping of the single oxygen atom by a substrate (triphenylphosphine)

Reaction of Dioxygen with a Cross-Conjugated Carbon-Carbon Double Bond in a Bis-Macrocycle Diiron Compound

Dioxygen at atmospheric pressure attacks a cross-conjugated carbon-carbon double bond in a diiron complex to form two, like, keto macrocyclic iron(II) complexes. This reaction occurs with high yield in both solution and in the solid state. A dioxetane intermediate is, therefore, invoked. The rate of the reaction is very dependent on the nature of the axial ligands on the low-spin iron(II) ions in the bimetallic complex. The rate is at least a factor of 104 faster with DMF ligands than with CH3CN axial ligands. This rate dependence is explained by stabilization of a peroxo biradical transition state en route to a dioxetane intermediate. The keto-macrocyle product has the carbonyl group conjugated with a β-diimine in a six-membered chelate ring. The conformation of this keto macrocycle is fixed on the NMR time scale and the spectra of all ten non-equivalent protons in the complex can be unambiguously assigned. The keto β-diimine ligand is an excellent π-acceptor as indicated by the high Fe(II) to Fe(III) oxidation potential of the compound and by the Mössbauer spectrum, which shows a low value for the center shift and a high value for the quadrupole splitting parameter